• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The discovery and development of HMG-CoA reductase inhibitors.

作者信息

Endo A

机构信息

Department of Applied Biological Science, Tokyo Noko University, Japan.

出版信息

J Lipid Res. 1992 Nov;33(11):1569-82.

PMID:1464741
Abstract
摘要

相似文献

1
The discovery and development of HMG-CoA reductase inhibitors.
J Lipid Res. 1992 Nov;33(11):1569-82.
2
Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.ML-236A和ML-236B真菌代谢产物对3-羟基-3-甲基戊二酰辅酶A还原酶的竞争性抑制作用，具有降胆固醇活性。1976年。
Atheroscler Suppl. 2004 Oct;5(3):39-42. doi: 10.1016/j.atherosclerosissup.2004.08.021.
3
Lowering plasma cholesterol by raising ldl receptors. 1981.
Atheroscler Suppl. 2004 Oct;5(3):57-9. doi: 10.1016/j.atherosclerosissup.2004.08.024.
4
Statins: in the beginning.
J R Coll Physicians Edinb. 2009 Dec;39(4):362-4. doi: 10.4997/jrcpe.2009.425.
5
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
Atheroscler Suppl. 2004 Oct;5(3):51-5. doi: 10.1016/j.atherosclerosissup.2004.08.023.
6
Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.HMG-CoA还原酶抑制剂单药治疗原发性高胆固醇血症的安全性和有效性的比较评估。
Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818.
7
Therapeutic effects of ml-236B in primary hypercholesterolemia. 1980.
Atheroscler Suppl. 2004 Oct;5(3):43-50. doi: 10.1016/j.atherosclerosissup.2004.08.022.
8
Biochemical aspect of HMG CoA reductase inhibitors.
Adv Enzyme Regul. 1989;28:53-64. doi: 10.1016/0065-2571(89)90063-0.
9
HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
Q J Med. 1990 Feb;74(274):111-5.
10
Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.高胆固醇血症中血小板、巨噬细胞和脂蛋白的相互作用：HMG-CoA还原酶抑制剂治疗的抗动脉粥样硬化作用。
J Cardiovasc Pharmacol. 1998 Jan;31(1):39-45. doi: 10.1097/00005344-199801000-00006.

引用本文的文献

1
The Potential Therapeutic Applications of Natural Products in the Oxidative Stress-Related MVA Pathway: Focus on HMGCR.天然产物在氧化应激相关甲羟戊酸途径中的潜在治疗应用：聚焦于3-羟基-3-甲基戊二酰辅酶A还原酶
Antioxidants (Basel). 2025 Aug 16;14(8):1001. doi: 10.3390/antiox14081001.
2
New benzoyl sesquiterpenoid, aoganolide, produced by Talaromyces sp. KTF-0021 strain (laeA-introduced mutant of FKI-5759 strain).新的苯甲酰倍半萜类化合物奥加内酯，由青霉属真菌KTF - 0021菌株（FKI - 5759菌株的laeA导入突变体）产生。
J Antibiot (Tokyo). 2025 Jul 25. doi: 10.1038/s41429-025-00851-6.
3
Cerebral Small Vessel Disease: Therapeutic Approaches Targeting Neuroinflammation, Oxidative Stress, and Endothelial Dysfunction.
脑小血管病：针对神经炎症、氧化应激和内皮功能障碍的治疗方法
Curr Issues Mol Biol. 2025 Mar 27;47(4):232. doi: 10.3390/cimb47040232.
4
Impact of statins in the liver: A bane or a boon?他汀类药物对肝脏的影响：是祸还是福？
Can Liver J. 2024 Mar 13;7(4):490-499. doi: 10.3138/canlivj-2023-0028. eCollection 2024 Dec.
5
Role of membrane microdomains in cardiac protection: strategies for diabetic cardiomyopathy.膜微区在心脏保护中的作用：糖尿病性心肌病的治疗策略
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H572-H591. doi: 10.1152/ajpheart.00139.2025. Epub 2025 Jul 10.
6
3-Hydroxy-3-methylglutaryl-CoA reductase variants strongly associated with low-density lipoprotein cholesterol levels and diabetes mellitus risk in a Taiwanese population: A Mendelian randomization study.3-羟基-3-甲基戊二酰辅酶A还原酶变异体与台湾人群低密度脂蛋白胆固醇水平及糖尿病风险密切相关：一项孟德尔随机化研究。
Tzu Chi Med J. 2025 Apr 7;37(2):181-188. doi: 10.4103/tcmj.tcmj_247_24. eCollection 2025 Apr-Jun.
7
Treatment of Homozygous Familial Hypercholesterolemia.纯合子家族性高胆固醇血症的治疗
JACC Adv. 2025 Apr 26;4(5):101708. doi: 10.1016/j.jacadv.2025.101708.
8
Short-term intake of delta-tocotrienol on lipid profiles in healthy subjects.健康受试者短期摄入δ-生育三烯酚对血脂谱的影响。
J Clin Biochem Nutr. 2025 Jan;76(1):3-7. doi: 10.3164/jcbn.24-124. Epub 2024 Oct 11.
9
Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics.将代谢药物二甲双胍和辛伐他汀重新用作一类新兴的癌症治疗药物。
Pharm Res. 2025 Jan;42(1):49-67. doi: 10.1007/s11095-024-03811-1. Epub 2025 Jan 7.
10
Evaluation of the toxicity potential of exercise and atorvastatin/metformin combination therapy on STZ-diabetic rats.运动与阿托伐他汀/二甲双胍联合治疗对链脲佐菌素诱导的糖尿病大鼠潜在毒性的评估。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5989-6007. doi: 10.1007/s00210-024-03663-x. Epub 2024 Dec 3.